Skip to main content
How it worksFeaturesGLP-1 trackerInjection trackerCalculatorLibraryPricing
Sign in

A calm place to organize an existing plan and understand the records around it.

Support: support@peptidegrid.site

Learn

  • How it works
  • Features
  • Library
  • Compare
  • FAQ
  • Evidence standards

Trackers

  • GLP-1 tracker
  • Peptide tracker
  • TRT tracker
  • Injection tracker
  • Calculator
  • Vial supply calculator
  • Inventory tracker
  • Pricing
  • Install the app
  • Help
  • Changelog

Trust

  • Calculation methodology
  • Safety methodology
  • Editorial standards
  • Privacy
  • Consumer health data
  • Medical disclaimer
  • Terms
© 2026 PeptideGridOrganizational and tracking tools; no diagnosis, prescribing, or dose recommendations.

Compound Library

Learn what each compound is, what has been studied, what remains uncertain, and what U.S. product information the sources cover before you organize an existing plan.

Peptides, hormones, and related compounds · U.S. context · no rankings.Compounds · U.S. context · no rankings.

Loading Saved Research…

Explore by topic

Start with a familiar context, then check the exact profile.

Metabolic & weight10 profilesHormones & endocrine8 profilesSkin & hair5 profilesRepair & immune6 profilesGrowth-hormone research5 profilesMitochondrial & sleep6 profiles

40 published profiles

  • Skin & hair · Cosmetic peptideAcetyl hexapeptide-8Also known as acetyl hexapeptide-3A synthetic cosmetic peptide, often called Argireline, studied mainly in topical anti-wrinkle formulations.EvidenceLimited human evidenceU.S. statusCosmetic ingredient; not a medicinePublished routeTopical
  • Skin & hair · Cosmetic peptideAcetyl octapeptide-3Also known as acetyl glutamyl heptapeptide-3A synthetic cosmetic peptide also called SNAP-8. Human evidence here comes from a specific multi-ingredient formulation, not the ingredient in isolation.EvidenceLimited human evidenceU.S. statusCosmetic ingredient; not a medicinePublished routeTopical
  • Skin & hair · Cosmetic peptideAHK-CuAlso known as AHK copperA copper complex of alanine-histidine-lysine studied in topical cosmetic and isolated hair-follicle research. It is distinct from GHK-Cu.EvidenceMostly preclinical evidenceU.S. statusCosmetic ingredient; not a medicinePublished routeTopical
  • Growth-hormone research · Research peptide fragmentAOD-9604Also known as AOD 9604A modified fragment related to human growth hormone studied in metabolic and weight-related research. It is not an FDA-approved drug.EvidenceClinical evidence not establishedU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Repair & immune · Research peptideBPC-157Also known as Body Protection Compound 157A synthetic fifteen-amino-acid peptide studied mainly in laboratory and animal models. It is not an FDA-approved drug.EvidenceMostly preclinical evidenceU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Hormones & endocrine · Peptide medicineBremelanotide / PT-141Also known as bremelanotideA melanocortin receptor agonist and active ingredient in Vyleesi, approved for a narrowly defined sexual-desire disorder population.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Metabolic & weight · Investigational peptideCagrilintideAlso known as AM833A long-acting amylin analogue studied alone and with semaglutide. It is not an FDA-approved drug.EvidenceHuman evidenceU.S. statusBeing studied; not FDA-approvedPublished routeSubcutaneous
  • Growth-hormone research · Research peptide analogueCJC-1295 with DACAlso known as CJC-1295 DACA long-acting growth-hormone-releasing-hormone analogue with an albumin-binding Drug Affinity Complex. It is distinct from the non-DAC form.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeSubcutaneous
  • Growth-hormone research · Research peptide analogueCJC-1295 without DACAlso known as CJC-1295 acetateA defined non-DAC, tetrasubstituted GHRH analogue. Commercial naming is inconsistent and it should not be treated as the DAC form.EvidenceClinical evidence not establishedU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Hormones & endocrine · Steroid hormoneDHEA / prasteroneAlso known as dehydroepiandrosteronePrasterone is another name for DHEA. U.S. prescription approval covers a specific vaginal product, not every oral supplement sold as DHEA.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeVaginal
  • Metabolic & weight · Peptide medicineDulaglutideAlso known as TrulicityA long-acting GLP-1 receptor agonist used in the FDA-approved Trulicity product for specific type 2 diabetes contexts.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Mitochondrial & sleep · Peptide medicineElamipretide / SS-31Also known as elamipretideA mitochondria-targeting peptide and active ingredient in Forzinity, an FDA-approved product for a narrow Barth syndrome population.EvidenceLimited human evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Mitochondrial & sleep · Research nonapeptideEmideltide (DSIP)Also known as delta sleep-inducing peptideThe defined nine-amino-acid peptide historically called delta sleep-inducing peptide or DSIP. It is not FDA approved.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeIntravenous
  • Mitochondrial & sleep · Research tetrapeptideEpitalonAlso known as AEDG peptideA defined four-amino-acid peptide discussed mainly in ageing-related laboratory and animal research. It is not an FDA-approved drug.EvidenceMostly preclinical evidenceU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Hormones & endocrine · Steroid hormoneEstradiolAlso known as 17 beta-estradiolAn estrogen hormone found in multiple FDA-approved products. Product, route, systemic exposure, and use can materially change the information that applies.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeIntramuscular, Oral, Transdermal, Vaginal
  • Metabolic & weight · Peptide medicineExenatideAlso known as Bydureon BCiseA GLP-1 receptor agonist used in FDA-approved products for type 2 diabetes. Immediate- and extended-release products have separate labels.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Skin & hair · Cosmetic peptideGHK-CuAlso known as copper peptideA copper complex of the tripeptide glycyl-L-histidyl-L-lysine discussed here in topical cosmetic and laboratory research, not as an injectable medicine.EvidenceLimited human evidenceU.S. statusCosmetic ingredient; not a medicinePublished routeTopical
  • Hormones & endocrine · Glycoprotein hormonehCGAlso known as chorionic gonadotropinA glycoprotein hormone found in FDA-approved prescription products for defined reproductive and endocrine uses. It is not FDA-approved for weight loss.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeIntramuscular
  • Growth-hormone research · Research peptideIpamorelinAlso known as ipamorelin acetateA synthetic growth-hormone secretagogue studied in early research. It is not an FDA-approved drug.EvidenceClinical evidence not establishedU.S. statusNo FDA-approved product identifiedPublished routeIntravenous
  • Repair & immune · Research tripeptideKPVAlso known as alpha-MSH(11-13)The three-amino-acid peptide lysine-proline-valine, studied in cell and animal inflammation models. It is not an FDA-approved drug.EvidenceMostly preclinical evidenceU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Metabolic & weight · Peptide medicineLiraglutideAlso known as SaxendaA GLP-1 receptor agonist used in FDA-approved products for specific diabetes and weight-management uses. The product label matters.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Metabolic & weight · Peptide medicineLixisenatideAlso known as AdlyxinA GLP-1 receptor agonist covered here mainly as one component of the fixed-ratio insulin glargine/lixisenatide product Soliqua 100/33.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Repair & immune · Research peptideLL-37Also known as cathelicidin LL-37A human antimicrobial peptide studied in innate immunity, inflammation, infection, and wound biology. It is not an FDA-approved drug.EvidenceMostly preclinical evidenceU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Mitochondrial & sleep · Research peptideMOTS-cAlso known as mitochondrial open reading frame of the 12S rRNA-cA mitochondrial-derived peptide studied in metabolism, exercise biology, ageing, and disease models. It is not an FDA-approved drug.EvidenceMostly preclinical evidenceU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Metabolic & weight · Nonpeptide small-molecule medicineOrforglipronAlso known as FoundayoAn oral, nonpeptide GLP-1 receptor agonist and the active ingredient in the FDA-approved Foundayo product.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeOral
  • Skin & hair · Cosmetic peptidePalmitoyl pentapeptide-4Also known as MatrixylA palmitoylated collagen-related peptide used in topical cosmetic formulations. Commercial ingredient names do not identify every finished product.EvidenceLimited human evidenceU.S. statusCosmetic ingredient; not a medicinePublished routeTopical
  • Metabolic & weight · Peptide medicinePramlintideAlso known as pramlintide acetateA synthetic analogue of amylin used in the FDA-approved SymlinPen product as an adjunct to mealtime insulin in defined diabetes contexts.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Hormones & endocrine · Steroid hormoneProgesteroneAlso known as micronized progesteroneA steroid hormone found in FDA-approved products, including oral micronized progesterone. It is distinct from synthetic progestins.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeOral
  • Metabolic & weight · Investigational peptideRetatrutideAlso known as LY3437943An investigational agonist of GIP, GLP-1, and glucagon receptors. It is being studied but is not an FDA-approved drug.EvidenceLimited human evidenceU.S. statusBeing studied; not FDA-approvedPublished routeSubcutaneous
  • Mitochondrial & sleep · Research peptideSelankAlso known as SelancA synthetic seven-amino-acid peptide studied in limited non-U.S. intranasal research. It is not FDA approved.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeNasal
  • Metabolic & weight · Peptide medicineSemaglutideAlso known as OzempicA GLP-1 receptor agonist and active ingredient in several FDA-approved U.S. products. The product, use, route, and label determine which information applies.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeOral, Subcutaneous
  • Mitochondrial & sleep · Research peptideSemaxAlso known as ACTH(4-7)-Pro-Gly-ProA synthetic peptide derived from an ACTH fragment, studied mainly in limited non-U.S. intranasal research. It is not FDA approved.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeNasal
  • Growth-hormone research · Research peptide analogueSermorelinAlso known as GerefA synthetic fragment of growth-hormone-releasing hormone. Historical Geref approvals do not validate current unapproved preparations or wellness claims.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeIntravenous, Subcutaneous
  • Hormones & endocrine · Protein hormone medicineSomatropinAlso known as GenotropinRecombinant human growth hormone found in FDA-approved products for specific growth-hormone and growth-failure conditions.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Repair & immune · Research peptide fragmentTB-500 (Ac-LKKTETQ fragment)Also known as Ac-LKKTETQA marketed name used inconsistently; this profile is limited to the defined Ac-LKKTETQ thymosin beta-4 fragment and not full-length thymosin beta-4.EvidenceClinical evidence not establishedU.S. statusNo FDA-approved product identifiedPublished routeNot separately published
  • Hormones & endocrine · Peptide medicineTesamorelinAlso known as Egrifta SVA growth-hormone-releasing factor analogue found in FDA-approved Egrifta products for a narrow HIV-associated lipodystrophy context.EvidenceHuman evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous
  • Hormones & endocrine · Steroid hormoneTestosteroneAlso known as AndroGelAn androgen hormone found in FDA-approved products. Delivery system, exposure, transfer risk, and the approved clinical context matter.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeIntramuscular, Nasal, Oral, Topical
  • Repair & immune · Research peptideThymosin alpha-1Also known as TA1A synthetic form of a naturally occurring immune-signalling peptide studied in infectious-disease, immune, and oncology contexts.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeSubcutaneous
  • Repair & immune · Research peptideThymosin beta-4Also known as TB4A naturally occurring actin-binding peptide studied in wound, corneal, inflammatory, and tissue-repair research. It is distinct from TB-500.EvidenceLimited human evidenceU.S. statusNo FDA-approved product identifiedPublished routeOphthalmic
  • Metabolic & weight · Peptide medicineTirzepatideAlso known as MounjaroA GIP and GLP-1 receptor agonist used in FDA-approved products for specific metabolic and weight-related uses. Brand labels are not interchangeable.EvidenceMore extensive human evidenceU.S. statusFDA-approved product for specific usesPublished routeSubcutaneous

Already organizing an existing routine?

Keep research separate from your personal record.

The Library stays a sourced reference. Use the Peptide Tracker for an existing peptide routine, or the TRT Tracker for an existing hormone injection routine.
Peptide Tracker TRT Tracker

Turn reading into prepared questions.

The full Library stays public. Saved Research reopens published profiles, while Shortlists remain your separate manual preparation lists. Neither selects a treatment or creates a plan from a profile.

See how tracking works Keep my research